-
CDMO Projects from Continuous Flow Technology
May , 22 2023
Continuous flow technology is becoming a strategic investment field of the world pharmaceutical group and CDMO. Large international pharmaceutical groups have applied continuous flow technology to the...
read more
-
Supercritical CO2 Crystallization Technology
Nov , 14 2023
Sinoway has been committed to new high-technology in pharmaceutical industry, serving all customers. Today, we will introduce Supercritical CO2 Crystallization Technology . What is Supercritical CO2 C...
read more
-
The effect of ADC Linkers in Precision Cancer Therapy
Dec , 20 2023
ADC (Antibody-Drug Conjugate) linkers play a crucial role in the efficacy and safety of ADC therapies, acting as the bridge between the antibody and the cytotoxic drug payload. Analyzing the pharmaceu...
read more
-
ADC linkers face several technical barriers in their development and utilization
Dec , 20 2023
Although ADC linker has been widely recognized in precision cancer therapy, ADC linker face several technical barriers in their development and utilization: 1. Chemical Stability: Designing linkers th...
read more
-
The R&D and manufacturing of ADC linker in China
Dec , 20 2023
With technological innovation, quality improvement, and international cooperation, the pharmaceutical intermediate manufacturing industry in China is in a rapid development stage. The R&D and manu...
read more
-
The Evolving Global Antibody Drug Conjugate (ADC) Technology Market: Growth Prospects, Challenges, and Advancements.
Jun , 25 2024
The rapid growth of the global ADC (Antibody Drug Conjugate) technology market indicates a significant increase in interest and investment in this area of biotherapeutics. ADCs have been recognized as...
read more
-
Advancing ADC Linker and Antibody Conjugation Technology for the Development of Homogenous Antibody Drug Conjugates
Jun , 25 2024
Rising interest in ADC linker and antibody conjugation technology for the development of homogenous antibody drug conjugates (ADCs) is driven by the need for targeted cancer therapies with improved sa...
read more
-
The key factors driving the ADC linker and antibody conjugation technologies market
Jun , 25 2024
The key factors driving the ADC linker and antibody conjugation technologies market can be summarized as follows: Growing Prevalence of Oncological Disorders: Cancer and other oncological disorders ha...
read more
-
Two types of Linkers Utilized in Antibody Drug Conjugates (ADCs): cleavable linkers and non-cleavable linkers.
Jun , 25 2024
In antibody drug conjugates (ADCs), two types of linkers are typically used: cleavable linkers and non-cleavable linkers. Cleavable linkers release the cytotoxic payload near the desired location with...
read more
IPv6 network supported
English
中文
français
Deutsch
русский
español
português
العربية
日本語
한국의
Türkçe
